Effect of chlorogenic acids on fatigue and sleep in healthy males: A randomized, double‐blind, placebo‐controlled, crossover study

von Ochiai, Ryuji, Tomonobu, Kazuichi, Ikushima, Ippei
Veröffentlicht in Food Sci Nutr (2018)

Insulin degludec/insulin aspart in Japanese patients with type 1 diabetes mellitus: Distinct prandial and basal glucose‐lowering effects

von Haahr, Hanne, Sasaki, Tomio, Bardtrum, Lars, Ikushima, Ippei
Veröffentlicht in J Diabetes Investig (2016)

Pharmacokinetic and pharmacodynamic properties of insulin degludec in Japanese patients with type 1 diabetes mellitus reflect similarities with Caucasian patients

von Ikushima, Ippei, Kaku, Kohei, Hirao, Koichi, Bardtrum, Lars, Haahr, Hanne
Veröffentlicht in J Diabetes Investig (2015)

Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects

von Harada, Akiko, Ikushima, Ippei, Haranaka, Miwa, Yanagihara, Aki, Nakayama, Daisuke
Veröffentlicht in Am J Cardiovasc Drugs (2019)

A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects

von Ikushima, Ippei, Jensen, Lene, Flint, Anne, Nishida, Tomoyuki, Zacho, Jeppe, Irie, Shin
Veröffentlicht in Adv Ther (2018)

Effects of concomitant use of prasugrel with edoxaban on bleeding time, pharmacodynamics, and pharmacokinetics of edoxaban in healthy elderly Japanese male subjects: a clinical pha...

von Ikushima, Ippei, Akasaka, Takaaki, Morishima, Yoshiyuki, Takita, Atsushi, Motohashi, Tomoko, Kimura, Tetsuya
Veröffentlicht in Thromb J (2020)

Safety, pharmacokinetics and pharmacodynamics of idarucizumab, a specific dabigatran reversal agent in healthy Japanese volunteers: a randomized study

von Yasaka, Masahiro, Ikushima, Ippei, Harada, Akiko, Imazu, Susumu, Taniguchi, Atsushi, Norris, Stephen, Gansser, Dietmar, Stangier, Joachim, Schmohl, Michael, Reilly, Paul A.
Veröffentlicht in Res Pract Thromb Haemost (2017)

Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies

von Norris, Stephen, Ramael, Steven, Ikushima, Ippei, Haazen, Wouter, Harada, Akiko, Moschetti, Viktoria, Imazu, Susumu, Reilly, Paul A., Lang, Benjamin, Stangier, Joachim, Glund, Stephan
Veröffentlicht in Br J Clin Pharmacol (2017)

Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes

von Shinozawa, Tadahiro, Nakamura, Koki, Shoji, Masanobu, Morita, Maya, Kimura, Maya, Furukawa, Hatsue, Ueda, Hiroki, Shiramoto, Masanari, Matsuguma, Kyoko, Kaji, Yoshikazu, Ikushima, Ippei, Yono, Makoto, Liou, Shyh-Yuh, Nagai, Hirofumi, Nakanishi, Atsushi, Yamamoto, Keiji, Izumo, Seigo
Veröffentlicht in Stem Cell Reports (2017)